While the increase in short interest for Gilead Sciences suggests that some investors are expecting the stock price to decline, the fact that it is still below the peer group average implies that the sentiment is not overwhelmingly negative. Additionally, the article suggests that an increase in short interest does not necessarily predict a near-term price drop, which makes the short-term impact neutral.